Everpure (P) Financials

Everpure’s latest results show strong top-line growth but a more mixed cash-flow picture. In Q2 2027, revenue increased to $1.19 billion from $1.05 billion in Q1 and $861.0 million in Q2 2026. This represents approximately 37.8% year-over-year growth and continues the company’s multi-year revenue expansion from $562.7 million in Q3 2022.

Profitability also improved sequentially. Gross profit rose to $811.4 million, producing a gross margin of approximately 68.4%, compared with 68.7% in Q1 and 70.2% in Q2 2026. Operating income increased sharply from $19.9 million in Q1 to $63.2 million in Q2, although the operating margin remained relatively modest at approximately 5.3%. Net income reached $74.1 million, or $0.21 per diluted share, up from $24.1 million, or $0.07 per diluted share, in Q1.

The longer-term earnings trend is positive but uneven. Everpure moved from a $67.4 million loss in Q1 2024 and a $14.0 million loss in Q1 2026 to quarterly profitability in each of the subsequent periods provided. However, Q2 2027 net income was below the $100.3 million reported in Q4 2026, suggesting that earnings growth may not be linear.

• Revenue momentum remains strong: Q2 2027 revenue grew nearly 38% year over year and was approximately 2.1 times Q3 2022 revenue.
• Operating profitability improved materially: Operating income rose from $19.9 million in Q1 2027 to $63.2 million in Q2, while net income more than tripled sequentially.
• Operating cash flow has historically been substantial: Cash generated from operations was $180.2 million in Q1 2027, $268.0 million in Q4 2026 and $212.2 million in Q2 2026.
• Share repurchases are reducing dilution pressure: The company repurchased $68.98 million of common stock in Q2 2027 after repurchasing $84.1 million in Q1 and $127.2 million in Q4 2026.
• Debt exposure appears limited: The latest balance sheet does not report short-term or long-term debt, reducing interest-rate and refinancing risk.
• Liquidity is investment-heavy: Cash and equivalents were $385.7 million, while short-term investments totaled $622.2 million. This provides approximately $1.01 billion of cash and short-term investments, but much of the liquidity is not held as cash.
• Capital investment remains elevated: Q2 2027 capital expenditures were $101.3 million, up from $68.4 million in Q1 and broadly consistent with the company’s ongoing investment in property and equipment.
• Q2 operating cash flow turned sharply negative: Everpure reported negative operating cash flow of $136.3 million despite $74.1 million of net income. A $422.9 million use of operating working capital was the primary cause.
• Cash balances declined materially: Cash fell from $837.8 million at the end of Q1 2027 to $385.7 million at the end of Q2, while net cash declined by $452.2 million during the quarter.
• Working-capital and balance-sheet risks are increasing: Accounts receivable rose to $1.03 billion, prepaid expenses reached $1.03 billion, total liabilities increased to $3.68 billion, and retained earnings remained negative at $1.08 billion.

For investors, the central issue is whether Everpure’s rapid revenue growth can translate into consistently positive operating cash flow. The company has meaningful liquid investments, no reported debt, and improving earnings, but the latest quarter’s large working-capital outflow and significant increase in receivables and prepaid assets warrant close monitoring.